Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China

Biomarkers

Volumn 16, Issue 1, 2011, Pages 37-41

  Huang, Cong Gai ^a   Iv, Guo Dong ^a   Liu, Tao ^a   Liu, Qing ^a   Feng, Jun Guo ^a   Lu, Xiao Mei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

COMT gene; Esophageal squamous cell carcinoma; polymorphisms; XPD gene

Indexed keywords

CATECHOL METHYLTRANSFERASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CHINA; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CATECHOL O-METHYLTRANSFERASE; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 79251481555     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.522732     Document Type: Article

References (29)

1. Afatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. (2004). Efect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specifc nitrosamine NNK. Environ Mol Mut 44:65-73.
2. Benhamou S, Sarasin A. (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17:463-9.
3. Berwick M, Vineis P. (2000). Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874-97.
4. Boer JG. (2002). Polymorphisms in DNA repair and environmental interactions. Mutat Res 509:201-10.
5. Cavalieri E, Frenkel K, Liehr J, Rogan E, Roy D. (2000). Oestrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst 27:75-93.
6. Cavalieri E, Stack D, Devanesan P, Todorovic R, Dwivedy I, Higginbotham S, Johansson S, Patil K, Gross M, Gooden J, Ramanathan R, Cerny R, Rogan E. (1997). Molecular origin of cancer: catechol oestrogen-3,4-quinones as endogenous tumour initiators. Proc Nat Acad Sci 94:10937-42.
7. Creveling CR, Inoue K. (1994). Catechol-O-methyltransferase: factors relating to the carcinogenic potential of catechol estrogens. Polycyclic Aromatic Compounds 6:253-9.
8. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61:6716-22.
9. Flores-Obando RE, Gollin SM, Ragin CC (2010). Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers 15:379-99.
10. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. (1999). Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870-5.
11. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Tun MJ. (2005). Cancer statistics, 2005. CA Cancer J Clin 55:302-10.
12. Kunugi H, Nanko S, Ueki. (1997). High and low activity alleles of cat-echol-O-methyltransferase gene: ethnic diference and possible association with Parkinson's disease. Neurosci Lett 221:202-4.
13. Laine JP, Mocquet V, Bonfanti M, Braun C, Egly JM, Brousset P. (2007). Common XPD (ERCC2) polymorphisms have no measurable efect on nucleotide excision repair and basal transcription. DNA Repair 6:1264-70.
14. Lambert R, Hainaut P. (2007). Te multidisciplinary management of gastrointestinal cancer: Epidemiology of oesophagogastric can-cer. Best Pract Res Clin Gastroenterol 21:921-45.
15. Lu JB, Yang WX, Liu JM, Li YS, Qin YM. (1985).Trends in morbidity and mortality for oesophageal cancer in Linxian County 1959-1983. Int J Cancer 36:643-5.
16. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G. (2006). XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HUGE review. Am J Epidemiol 164:297-302.
17. Miller SA, Dybes DD, Polesky HF. (1988).A simple salting out proce-dure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215-19.
18. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. (1998). Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 19: 1943-1947.
19. Rzeszowska-Wolny J, Polanska J, Pietrowska M, Palyvoda O, Jaworsk J, Butkiewicz D, Hancock R. (2005). Infuence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro. Radiation Res 164:132-40.
20. Shen MR, Jones IM, Mohrenweiser H. (1998). Non conservative amino acid substitution variants exist at polymorphic frequency DNA repair genes in healthy humans. Cancer Res 58:604-8.
21. Spitz MR, Wu X, Wang Y Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H. Wei Q. (2001). Modulation of nucleotide exci-sion repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354-7.
22. Stewart BW, Kleihues P. (2003). World Cancer Report. Lyon: IARC Press. p. 223-7.
23. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I. (1997). Genetic polymor-phism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and com-parison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 7:65-71.
24. Tompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB. (1998). Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58:2107-10.
25. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis J P, Matullo G (2009). A feld synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36.
26. Wang F, Chang D, Hu FI, Sui H, Han B, li DD, Zhao YS. (2008). DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev 17:507-17.
27. Wood RD. (1999). DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81:39-44.
28. Yager JD. (2000). Chapter 3: endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst 27:67-73.
29. Zhang YM. (1988). Te distribution of esophageal cancer in Xinjiang. Xinjiang Yixueyuan Xuebao 11:139-44.